An observational study in Splenectomy; Status, sponsored by University Hospital, Montpellier. Status unknown at 1 site in France. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2022-01-11.
Sponsored by University Hospital, Montpellier · Observational
Partial splenectomy or total splenectomy are the two surgical treatment of non-malignant hemoglobinoptahie. The aim of this treatment is to decrease transfusion. The main risk is infectious in total splenectomy, that's why partial splenectomy was suggest. But the efficiency of partial splenectomy decrease over time and a totalisation could be mandatory.
University Hospital, Montpellier is the lead sponsor of 1,261 studies on the registry; 226 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children under 18 years olds with partial or total splenectomy for non malignant hemoglobinopathies
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
- Total or partial splenectomy outside of non malignant hemoglobinopathies
Children under 18 years olds with total splenectomy for non Malignant hemoglobinopathie
Children under 18 years olds with partial splenectomy for non Malignant hemoglobinopathie
Compared the effectiveness with the number of transfusion
Compared the effectiveness with the number of transfusion after the surgery between total and partial Febrile urinary tract infection was defined as a positive urine examination with a single bacteria with more than 10.5 cfu/mL and more than 10.4 leukocytes/ml associated with fever above 38.5°C and C-reactive protein (CRP) above 50 mg/
Time frame: Day 1
Number of infectious event in total and partial splenectomy
Number of infectious event in total and partial splenectomy
Time frame: Day 1
number of totalisation in partial
number of totalisation in partial
Time frame: Day 1
Plan to share: Undecided — NC
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier →